CIK: 0001472322
Total reported value
$2.7B
Reporting period: 2026-03-31 · Number of holdings: 152
Nantahala Capital Management, LLC disclosed 152 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $2.7B and a quarterly turnover rate of 40.1%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "N"
Nantahala Capital Management, LLC's disclosed holdings carry a Herfindahl concentration index of 0.048 — mathematically equivalent to about 21 equally-sized positions, well below its 152 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 2.38), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 15% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim IWM
-27.2% -$185.1M
Trim EW
-55.6% -$89.4M
Add PTON
+140.8% $51.9M
Add QURE
+305.7% $29.7M
Trim TEVA
-40.0% -$32.8M
Trim FULC
-29.0% -$25.2M
Showing top 137 holdings (of 152 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 18.72% | -4.21% | -27.23% | |
| 2 | PTON | Peloton Interactive Inc-a | Stock-Consumer Disc | 4.73% | +2.20% | +140.81% | |
| 3 | HLF | Herbalife Ltd. | Stock-Other | 3.77% | +0.07% | -19.91% | |
| 4 | HGV | Hilton Grand Vacations INC | Stock-Other | 3.73% | -0.17% | -1.82% | |
| 5 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 3.07% | — | +37.34% | |
| 6 | TBBK | Bancorp Inc/the | Stock-Other | 2.98% | +0.59% | +40.55% | |
| 7 | VTRS | Viatris INC | Stock-Healthcare | 2.49% | — | — | |
| 8 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 2.36% | -2.71% | -55.56% | |
| 9 | BVS | Bioventus INC - A | Stock-Other | 2.06% | +0.57% | +1.24% | |
| 10 | ✓ | Establishment Labs Hldgs INC | Stock-Other | 1.74% | -0.64% | -15.67% | |
| 11 | QURE | uniQure N.V. | Stock-Other | 1.71% | +1.16% | +305.70% | |
| 12 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 1.66% | -0.92% | -40.00% | |
| 13 | SVRA | Savara INC | Stock-Other | 1.48% | — | — | |
| 14 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 1.41% | -0.20% | -25.00% | |
| 15 | XTNT | Xtant Medical Holdings INC | Stock-Other | 1.40% | -0.37% | — | |
| 16 | FOXF | Fox Factory Holding CORP | Stock-Other | 1.39% | — | +4.57% | |
| 17 | CWH | Camping World Holdings Inc-a | Stock-Other | 1.32% | +0.34% | +71.95% | |
| 18 | GOGO | Gogo INC | Stock-Other | 1.31% | — | +30.76% | |
| 19 | AMRX | Amneal Pharmaceuticals INC | Stock-Other | 1.30% | — | +16.20% | |
| 20 | RDNW | Ridenow Group INC | Stock-Other | 1.29% | +0.38% | — | |
| 21 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 1.14% | — | — | |
| 22 | AVR | Anteris Technologies Global | Stock-Other | 1.13% | +0.71% | +118.53% | |
| 23 | ETON | Eton Pharmaceuticals INC | Stock-Other | 1.07% | +0.41% | — | |
| 24 | ABEO | Abeona Therapeutics INC | Stock-Other | 1.00% | — | +10.03% | |
| 25 | EOLS | Evolus INC | Stock-Other | 0.96% | -0.32% | +9.56% | |
| 26 | TNGX | Tango Therapeutics INC | Stock-Other | 0.96% | — | -65.00% | |
| 27 | LBRX | Lb Pharmaceuticals INC | Stock-Other | 0.96% | +0.46% | +55.98% | |
| 28 | MLYS | Mineralys Therapeutics INC | Stock-Other | 0.89% | +0.75% | +690.47% | |
| 29 | ZVRA | Zevra Therapeutics INC | Stock-Other | 0.87% | +0.35% | +42.33% | |
| 30 | FULC | Fulcrum Therapeutics INC | Stock-Other | 0.86% | -0.75% | -28.96% | |
| 31 | FOSL | Fossil Group INC | Stock-Other | 0.86% | — | +6.71% | |
| 32 | ✓ | Adc Therapeutics SA | Stock-Other | 0.77% | — | +2.23% | |
| 33 | TITN | Titan Machinery INC | Stock-Other | 0.77% | — | +2.79% | |
| 34 | IMAX | Imax CORP | Stock-Other | 0.72% | — | +8.06% | |
| 35 | VSTM | Verastem INC | Stock-Other | 0.70% | +0.58% | +675.70% | |
| 36 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 0.70% | +0.35% | +46.52% | |
| 37 | AVTX | Avalo Therapeutics INC | Stock-Other | 0.68% | — | — | |
| 38 | RMR | Rmr Group Inc/the - A | Stock-Other | 0.65% | — | — | |
| 39 | RYAM | Rayonier Advanced Materials | Stock-Other | 0.65% | +0.30% | -11.11% | |
| 40 | ALGN | Align Technology INC | Stock-Healthcare | 0.63% | — | — | |
| 41 | GERN | Geron CORP | Stock-Other | 0.62% | — | +24.38% | |
| 42 | PCVX | Vaxcyte INC | Stock-Other | 0.59% | +0.54% | +678.26% | |
| 43 | BNTC | Benitec Biopharma INC | Stock-Other | 0.56% | — | +38.52% | |
| 44 | ABVX | Abivax Sa-adr | Stock-Other | 0.56% | — | -10.44% | |
| 45 | ITGR | Integer Holdings CORP | Stock-Healthcare | 0.56% | +0.30% | +68.63% | |
| 46 | RH | Rh | Stock-Consumer Disc | 0.55% | — | +22.78% | |
| 47 | KROS | Keros Therapeutics INC | Stock-Other | 0.55% | — | +122.87% | |
| 48 | CHYM | Chime Financial Inc-cl A | Stock-Other | 0.55% | — | +33.33% | |
| 49 | JACK | Jack In THE Box INC | Stock-Other | 0.55% | — | +78.14% | |
| 50 | JCAP | Jefferson Capital INC | Stock-Other | 0.53% | — | +25.00% |
Performance for Q3 2026
+6.7%
Performance Last 4 Quarters
-8.6%
Based on 77% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 152 | $2.7B | 40 | |
| 2025-12-31 | 153 | $3.0B | 35 | |
| 2025-09-30 | 153 | $2.9B | 68 | |
| 2025-06-30 | 158 | $2.6B | 0 | |
| 2025-03-31 | 145 | $2.5B | 100 | |
| 2024-12-31 | 137 | $2.3B | 0 | |
| 2024-09-30 | 140 | $2.0B | 0 | |
| 2024-06-30 | 130 | $1.7B | 0 | |
| 2024-03-31 | 124 | $1.8B | 0 | |
| 2023-12-31 | 128 | $1.7B | 0 | |
| 2023-09-30 | 133 | $1.2B | 0 | |
| 2023-06-30 | 124 | $1.0B | 0 | |
| 2023-03-31 | 124 | $1.3B | 0 | |
| 2022-12-31 | 118 | $1.5B | 0 | |
| 2022-09-30 | 120 | $1.5B | 0 | |
| 2022-06-30 | 124 | $2.0B | 0 | |
| 2022-03-31 | 122 | $2.3B | 0 | |
| 2021-12-31 | 136 | $2.8B | 0 | |
| 2021-09-30 | 130 | $3.2B | 0 | |
| 2021-06-30 | 121 | $3.5B | 43 | |
| 2021-03-31 | 116 | $3.4B | 53 | |
| 2020-12-31 | 126 | $3.2B | 44 | |
| 2020-09-30 | 130 | $3.3B | 39 | |
| 2020-06-30 | 130 | $3.3B | 39 | |
| 2020-03-31 | 124 | $2.7B | 64 | |
| 2019-12-31 | 106 | $3.2B | 46 | |
| 2019-09-30 | 108 | $2.7B | 35 | |
| 2019-06-30 | 111 | $3.2B | 41 | |
| 2019-03-31 | 115 | $3.2B | 36 | |
| 2018-12-31 | 124 | $3.3B | 33 | |
| 2018-09-30 | 119 | $3.7B | 52 | |
| 2018-06-30 | 102 | $2.5B | 36 | |
| 2018-03-31 | 97 | $2.2B | 31 | |
| 2017-12-31 | 91 | $2.2B | 40 | |
| 2017-09-30 | 82 | $2.0B | 56 | |
| 2017-06-30 | 72 | $1.3B | 61 | |
| 2017-03-31 | 60 | $897.7M | 57 | |
| 2016-12-31 | 71 | $963.3M | 36 | |
| 2016-09-30 | 67 | $829.4M | 54 | |
| 2016-06-30 | 73 | $922.5M | 34 | |
| 2016-03-31 | 78 | $972.1M | 46 | |
| 2015-12-31 | 74 | $766.5M | 33 | |
| 2015-09-30 | 78 | $736.7M | 40 | |
| 2015-06-30 | 82 | $681.6M | 44 | |
| 2015-03-31 | 91 | $601.0M | 54 | |
| 2014-12-31 | 107 | $712.5M | 48 | |
| 2014-09-30 | 136 | $814.6M | 48 | |
| 2014-06-30 | 117 | $679.8M | 47 | |
| 2014-03-31 | 107 | $622.7M | 67 | |
| 2013-12-31 | 124 | $616.7M | 75 | |
| 2013-09-30 | 91 | $446.7M | 60 | |
| 2013-06-30 | 101 | $431.8M | 0 |
Nantahala Capital Management, LLC's most significant position changes for 2026-03-31: Sold out: Eventbrite Inc-class A (EB4); Sold out: Rapt Therapeutics INC (RAPT); Sold out: Globus Medical INC - A (GMED); Sold out: Live Nation Entertainment In (LYV); Sold out: Astria Therapeutics INC (CATBUSD).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PTON | Peloton Interactive Inc-a | +2.2% | +140.81% | Add |
| 2 | QURE | uniQure N.V. | +1.2% | +305.70% | Add |
| 3 | MLYS | Mineralys Therapeutics INC | +0.8% | +690.47% | Add |
| 4 | AVR | Anteris Technologies Global | +0.7% | +118.53% | Add |
| 5 | TBBK | Bancorp Inc/the | +0.6% | +40.55% | Add |
| 6 | VSTM | Verastem INC | +0.6% | +675.70% | Add |
| 7 | BVS | Bioventus INC - A | +0.6% | +1.24% | Add |
| 8 | PCVX | Vaxcyte INC | +0.5% | +678.26% | Add |
| 9 | LBRX | Lb Pharmaceuticals INC | +0.5% | +55.98% | Add |
| 10 | ETON | Eton Pharmaceuticals INC | +0.4% | — | Unchanged |
| 11 | RDNW | Ridenow Group INC | +0.4% | — | Unchanged |
| 12 | GLUE | Monte Rosa Therapeutics INC | +0.4% | +1024.30% | Add |
| 13 | BCRX | Biocryst Pharmaceuticals INC | +0.4% | +46.52% | Add |
| 14 | ZVRA | Zevra Therapeutics INC | +0.4% | +42.33% | Add |
| 15 | CWH | Camping World Holdings Inc-a | +0.3% | +71.95% | Add |
| 16 | AH30 | Assertio Holdings INC | +0.3% | +17.88% | Add |
| 17 | ITGR | Integer Holdings CORP | +0.3% | +68.63% | Add |
| 18 | RYAM | Rayonier Advanced Materials | +0.3% | -11.11% | Trim |
| 19 | HLF | Herbalife Ltd. | +0.1% | -19.91% | Trim |
| 20 | HGV | Hilton Grand Vacations INC | -0.2% | -1.82% | Trim |
| 21 | TLSI | Trisalus Life Sciences INC | -0.2% | — | Unchanged |
| 22 | IRON | Disc Medicine INC | -0.2% | -49.81% | Trim |
| 23 | XBI | Ss Spdr S&p Biotech ETF | -0.2% | -25.00% | Trim |
| 24 | CRMT | America's Car-mart INC | -0.2% | — | Unchanged |
| 25 | PEPG | Pepgen INC | -0.3% | -55.98% | Trim |
| 26 | DNTH | Dianthus Therapeutics INC | -0.3% | -82.06% | Trim |
| 27 | UPB | Upstream Bio INC | -0.3% | -19.19% | Trim |
| 28 | EOLS | Evolus INC | -0.3% | +9.56% | Add |
| 29 | XTNT | Xtant Medical Holdings INC | -0.4% | — | Unchanged |
| 30 | GUTS | Fractyl Health INC | -0.6% | +23.22% | Add |
| 31 | ✓ | Establishment Labs Hldgs INC | -0.6% | -15.67% | Trim |
| 32 | FULC | Fulcrum Therapeutics INC | -0.8% | -28.96% | Trim |
| 33 | TEVA | Teva Pharmaceutical-sp Adr | -0.9% | -40.00% | Trim |
| 34 | EW | Edwards Lifesciences CORP | -2.7% | -55.56% | Trim |
| 35 | IWM | Ishares Russell 2000 ETF | -4.2% | -27.23% | Trim |
| 36 | EB4 | Eventbrite Inc-class A | — | EXIT | Sold out |
| 37 | RAPT | Rapt Therapeutics INC | — | EXIT | Sold out |
| 38 | GMED | Globus Medical INC - A | — | EXIT | Sold out |
| 39 | LYV | Live Nation Entertainment In | — | EXIT | Sold out |
| 40 | CATBUSD | Astria Therapeutics INC | — | EXIT | Sold out |
| 41 | AGMB | Agomab Therapeutics NV | — | NEW | New buy |
| 42 | ✓ | Helix Acquisition CORP Iii | — | NEW | New buy |
| 43 | JANX | Janux Therapeutics INC | — | NEW | New buy |
| 44 | GDEN | Golden Entertainment INC | — | EXIT | Sold out |
| 45 | DUOL | Duolingo | — | NEW | New buy |
| 46 | CASH | Pathward Financial INC | — | EXIT | Sold out |
| 47 | QNCX | Quince Therapeutics, Inc. | — | EXIT | Sold out |
| 48 | CMCO | Columbus Mckinnon Corp/ny | — | EXIT | Sold out |
| 49 | DMRA | Damora Therapeutics INC | — | NEW | New buy |
| 50 | VENU | Venu Holding CORP | — | NEW | New buy |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-20 | Amendment | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-15 | Amendment | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-10 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-13 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-14 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-16 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-14 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-14 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-15 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-16 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-13 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-08-14 | Amendment | View on EDGAR |
| 2015-03-31 | 2015-05-15 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-17 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-11-14 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-08-14 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-05-15 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
| 2013-09-30 | 2013-11-14 | 13F-HR | View on EDGAR |
| 2013-06-30 | 2013-08-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001034541
Total reported value
$2.7B
28 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001331875
Total reported value
$2.7B
21 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001565332
Total reported value
$2.7B
10 stks
2026-03-31
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001033427
Total reported value
$246.7M
44 stks
2026-03-31
2 of the top 5 holdings overlap, including Herbalife Ltd.
CIK 0001680326
Total reported value
$199.5M
29 stks
2018-06-30
Stale — no recent filing
2 of the top 5 holdings overlap, including Ishares Russell 2000 ETF
CIK 0000049096
Total reported value
$113.6M
427 stks
2024-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Ishares Russell 2000 ETF